metoprolol has been researched along with Abnormality, Heart in 8 studies
Metoprolol: A selective adrenergic beta-1 blocking agent that is commonly used to treat ANGINA PECTORIS; HYPERTENSION; and CARDIAC ARRHYTHMIAS.
metoprolol : A propanolamine that is 1-(propan-2-ylamino)propan-2-ol substituted by a 4-(2-methoxyethyl)phenoxy group at position 1.
| Excerpt | Relevance | Reference |
|---|---|---|
| " Studies investigating any of three beta blockers (carvedilol, bisoprolol, and extended release metoprolol succinate) which are known to be effective in adult patients with heart failure were included." | 4.91 | Effects of beta-blockers for congestive heart failure in pediatric and congenital heart disease patients: a meta-analysis of published studies. ( Cho, MJ; Jung Kwak, M; Kim, HY; Kim, YM; Lee, HD; Lim, RK; Park, KH, 2015) |
| "Metoprolol was prescribed to relieve obstruction and symptoms." | 1.40 | Mitral valve with a single leaflet. ( Bezgin, T; Çanga, Y; Elveran, A; Karagöz, A; Yılmaz, F, 2014) |
| "Pretreatment with metoprolol tartrate at any dose did not significantly reduce terbutaline's potential." | 1.29 | Cardiovascular teratogenicity of terbutaline and ritodrine in the chick embryo. ( Kolesari, GL; Kuhlmann, RS; Lawrence, JM; Lenselink, DR, 1994) |
| "Metoprolol pretreatment has been shown to reduce the cardiovascular malformation rate produced by topical doses of dopamine in the stage 24 chick embryo." | 1.28 | Tissue and plasma levels of a teratogenic dose of dopamine in the chick embryo following pretreatment with metoprolol or phosphate buffered saline. ( Kolesari, GL; Kuhlmann, RS; Shields, HE, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (12.50) | 18.7374 |
| 1990's | 2 (25.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duan, L | 1 |
| Ng, A | 1 |
| Chen, W | 1 |
| Spencer, HT | 1 |
| Nguyen, J | 1 |
| Shen, AY | 1 |
| Lee, MS | 1 |
| Bodi, I | 1 |
| Franke, G | 1 |
| Pantulu, ND | 1 |
| Wu, K | 1 |
| Perez-Feliz, S | 1 |
| Bode, C | 1 |
| Zehender, M | 1 |
| zur Hausen, A | 1 |
| Brunner, M | 1 |
| Odening, KE | 1 |
| Abriel, H | 1 |
| Rougier, JS | 1 |
| Bezgin, T | 1 |
| Elveran, A | 1 |
| Karagöz, A | 1 |
| Çanga, Y | 1 |
| Yılmaz, F | 1 |
| Cho, MJ | 1 |
| Lim, RK | 1 |
| Jung Kwak, M | 1 |
| Park, KH | 1 |
| Kim, HY | 1 |
| Kim, YM | 1 |
| Lee, HD | 1 |
| Cameron, RH | 1 |
| Kolesari, GL | 3 |
| Kalbfleisch, JH | 1 |
| Lenselink, DR | 1 |
| Kuhlmann, RS | 2 |
| Lawrence, JM | 1 |
| Shields, HE | 1 |
1 review available for metoprolol and Abnormality, Heart
| Article | Year |
|---|---|
Effects of beta-blockers for congestive heart failure in pediatric and congenital heart disease patients: a meta-analysis of published studies.
Topics: Adrenergic beta-Antagonists; Age Factors; Bisoprolol; Carbazoles; Carvedilol; Child; Heart Defects, | 2015 |
7 other studies available for metoprolol and Abnormality, Heart
| Article | Year |
|---|---|
β-Blocker Exposure in Pregnancy and Risk of Fetal Cardiac Anomalies.
Topics: Adrenergic beta-Antagonists; Age Factors; Arrhythmias, Cardiac; Atenolol; Body Mass Index; Californi | 2017 |
Differential effects of the β-adrenoceptor blockers carvedilol and metoprolol on SQT1- and SQT2-mutant channels.
Topics: Action Potentials; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Carbazoles; Carvedilo | 2013 |
β-blockers in congenital short-QT syndrome as ion channel blockers.
Topics: Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Carbazoles; Ether-A-Go-Go Potassium Chan | 2013 |
Mitral valve with a single leaflet.
Topics: Adrenergic beta-1 Receptor Antagonists; Echocardiography, Transesophageal; Female; Heart Defects, Co | 2014 |
Pharmacology of dextroamphetamine-induced cardiovascular malformations in the chick embryo.
Topics: Abnormalities, Drug-Induced; alpha-Methyltyrosine; Animals; Chick Embryo; Dextroamphetamine; Heart D | 1983 |
Cardiovascular teratogenicity of terbutaline and ritodrine in the chick embryo.
Topics: Animals; Butoxamine; Chick Embryo; Dose-Response Relationship, Drug; Heart Defects, Congenital; Meto | 1994 |
Tissue and plasma levels of a teratogenic dose of dopamine in the chick embryo following pretreatment with metoprolol or phosphate buffered saline.
Topics: Animals; Buffers; Chick Embryo; Dopamine; Heart Defects, Congenital; Metoprolol; Time Factors; Tissu | 1990 |